Clinical trial
An Observational, Bidirectional Cohort Study to Evaluate T-cell Developmental Status in Patients With Malignant Hematological Tumors
NCT07035938 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational, Bidirectional Cohort Study to Evaluate T-cell Developmental Status in Patients With Malignant Hematological Tumors
- Lead sponsor
- The First Affiliated Hospital of Xiamen University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 22, 2025
- Completion date
- June 30, 2028
- Enrollment
- 75 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hematologic malignancy